EP Patent

EP1459739A1 — Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids

Assigned to Jordanian Pharmaceutical Manufacturing Co · Expires 2004-09-22 · 22y expired

What this patent protects

A wet granulation formulation for oral dosage forms containing a non-hydrated quinoline carboxylic acid type antibacterial agent with low water content and non-hygroscopic properties.

USPTO Abstract

A wet granulation formulation for oral dosage forms containing a non-hydrated quinoline carboxylic acid type antibacterial agent with low water content and non-hygroscopic properties.

Drugs covered by this patent

Patent Metadata

Patent number
EP1459739A1
Jurisdiction
EP
Classification
—
Expires
2004-09-22
Drug substance claim
No
Drug product claim
No
Assignee
Jordanian Pharmaceutical Manufacturing Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.